104 related articles for article (PubMed ID: 6836956)
1. [Effect of the antioxidant OP-6 on some model reactions of the blood coagulation system].
Kleĭmenov AN; Rozenfel'd MA; Burlakova EB; Zenkov IuV; Shvedova AA
Vopr Med Khim; 1983; 29(1):33-7. PubMed ID: 6836956
[TBL] [Abstract][Full Text] [Related]
2. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
3. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
4. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
Pozdniakova TM; Rybachuk VN; Vovk Ev
Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of the fluid state of the blood and the problems of pathophysiology].
Kudriashov BA
Probl Gematol Pereliv Krovi; 1979 Jul; 24(7):13-9. PubMed ID: 382181
[No Abstract] [Full Text] [Related]
7. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
Haskel EJ; Eisenberg PR; Abendschein DR
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of inhibition of fibrin polymerization by fibrinogen and its active fragments].
Belitser VA; Varetskaia TV; Kosterin SA
Biokhimiia; 1980 Jan; 45(1):157-64. PubMed ID: 7213830
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a 3-hydroxypyridine-class antioxidant on the functional activity of the central nervous system in mice of different age groups].
Voronina TA; Kutepova OA
Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1126-31. PubMed ID: 3245323
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation and fibrin clot structure.
Wolberg AS
Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen and fibrin: scaffold proteins in hemostasis.
Lord ST
Curr Opin Hematol; 2007 May; 14(3):236-41. PubMed ID: 17414213
[TBL] [Abstract][Full Text] [Related]
14. [Effect of sulodexide on hemocoagulation and lipid peroxidation in athletes during physical load].
Mukhanov OA; Ordzhonikidze ZG; Lioshenko VG; Seĭfulla RD
Eksp Klin Farmakol; 2002; 65(2):38-9. PubMed ID: 12109291
[TBL] [Abstract][Full Text] [Related]
15. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
16. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
17. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
[TBL] [Abstract][Full Text] [Related]
18. [Effect of the antioxidant ionol on blood coagulation and fibrinolysis].
Mishchenko VP; Gol'denberg IuM; Novosel'tseva TV
Vopr Med Khim; 1980; 26(6):763-7. PubMed ID: 7456408
[No Abstract] [Full Text] [Related]
19. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
20. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
